Evogene to Receive $3.5 million Payment Related to Patent Portfolio under its Existing Seed Traits Collaboration with Bayer
10 December 2022, Israel: Evogene Ltd., a leading computational biology company targeting to revolutionize life-science product discovery and development across multiple market
Read More